Clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million euros to test a new immunotherapy approach
While CAR-T cells have proven successful in treating certain types of leukemia and lymphoma, these immunotherapies can become even more effective. A clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million…